Phase 2Recruiting
Mammogram Pretreatment With Ulipristal Acetate
Progesterone Receptor Modulator Mammogram Pretreatment for Premenopausal People With a History of Dense Breast Tissue
- Sponsor
- OHSU Knight Cancer Institute (Academic or other)
- Enrollment
- 26 planned
- Conditions
- Mammography Screening; Breast Density
- Interventions
- Biospecimen Collection; Magnetic Resonance Imaging; Mammogram; Survey Administration; Ulipristal Acetate
- Ages
- adults
- Registry
- NCT07434128
Full record on ClinicalTrials.gov
From the registry
This phase II trial tests whether taking ulipristal acetate prior to a mammogram decreases breast density for people with a history of dense breast tissue. One limitation to breast cancer screening with mammography is dense breast tissue, which decreases the sensitivity of screening as breast density masks cancer and precancerous lesions. Ulipristal acetate lowers the amount of progesterone made by the body which may temporarily decrease the density of the breast tissue, allowing for a more accurate mammogram for people with dense breast tissue.
Primary outcomes
- Difference in percent dense area
History
Primary completion expected
Last registry update
Started
Registered